35.96
Finanzdaten der Medline Inc-Aktie (MDLN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-27 | 2026-03-28 |
| Periodenlänge | 3 Monate | 3 Monate |
| Revenues |
4.53%
7,685.00
|
7,352.00 |
| Cost Of Revenue |
0.74%
5,470.00
|
5,511.00 |
| Gross Profit |
20.32%
2,215.00
|
1,841.00 |
| Operating Expenses |
28.26%
1,820.00
|
1,419.00 |
| Operating Income/Loss |
6.40%
395.00
|
422.00 |
| Nonoperating Income/Loss |
22.14%
-160.00
|
-131.00 |
| Income/Loss From Continuing Operations Before Tax |
19.24%
235.00
|
291.00 |
| Income Tax Expense/Benefit, Deferred |
72.97%
64.00
|
37.00 |
| Income Tax Expense/Benefit |
84.62%
96.00
|
52.00 |
| Net Income/Loss |
41.84%
139.00
|
239.00 |
| Preferred Stock Dividends And Other Adjustments |
133.33%
1.00
|
-3.00 |
| Attributable To Noncontrolling Interest |
28.18%
79.00
|
110.00 |
| Basic Average Shares |
4.59%
856.67
|
819.08 |
| Diluted Average Shares |
4.37%
860.89
|
824.84 |
| Basic Earnings Per Share |
56.25%
0.07
|
0.16 |
| Diluted Earnings Per Share |
56.25%
0.07
|
0.16 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):